GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.610
-0.070 (-1.50%)
Apr 28, 2025, 4:00 PM EDT - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 8.39, with a low estimate of 5.50 and a high estimate of 16. The average target predicts an increase of 82.00% from the current stock price of 4.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 9 | 9 | 9 | 8 | 8 | 6 |
| Hold | 5 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 14 | 14 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $6.5 → $5.5 | Hold | Maintains | $6.5 → $5.5 | +19.31% | Apr 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +73.54% | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +35.57% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +30.15% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +30.15% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
839.68M
from 792.32M
Increased by 5.98%
Revenue Next Year
893.24M
from 839.68M
Increased by 6.38%
EPS This Year
0.41
from 0.04
Increased by 926.68%
EPS Next Year
0.48
from 0.41
Increased by 17.44%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 878.1M | 958.3M | 1.1B | ||
| Avg | 839.7M | 893.2M | 953.6M | ||
| Low | 796.3M | 833.2M | 875.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.8% | 14.1% | 17.7% | ||
| Avg | 6.0% | 6.4% | 6.8% | ||
| Low | 0.5% | -0.8% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.47 | 0.53 | 0.66 | ||
| Avg | 0.41 | 0.48 | 0.54 | ||
| Low | 0.34 | 0.43 | 0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1,081.3% | 27.8% | 37.2% | ||
| Avg | 926.7% | 17.4% | 11.1% | ||
| Low | 757.5% | 5.0% | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.